STOCK TITAN

Zai Lab (ZLAB) EPS by Year

ZLAB NASDAQ

Zai Lab Limited lost $0.16 per diluted ordinary share in fiscal year 2025. The change from the prior fiscal year is not meaningful, because that figure was zero or negative. Over the trailing 12 months, Q4 FY2025 through Q3 FY2026, the same line adds up to a loss of $0.19 per diluted ordinary share. The table below carries 11 fiscal years, from 2015 to 2025, and the quarters Zai Lab Limited has filed alongside them.

FY2025 annual
EPS (Diluted) -$0.16
YoY n/m
Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Sep 30, 2026 Reported Currency USD

Earnings and dividends per share are per ordinary share, and share counts are in ordinary shares. ZLAB trades in the US as American depositary shares (ADSs), and one ADS represents 10 ordinary shares.

Annual figures, oldest first. Point at a bar to read its period.

ZLAB EPS (Diluted) by Fiscal Year

Figures are in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-K
EPS (Diluted)-$0.19-$0.16n/m-$0.26n/m-$0.35n/m-$0.46n/m-$0.76-$0.35-$3.03n/m-$2.64-$2.32-$3.97n/m-$2.07

TTM is the trailing twelve months, Q4 FY2025 through Q3 FY2026, summed from the four most recent quarterly filings.

ZLAB EPS (Diluted) by Quarter

Figures are in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-K
EPS (Diluted)-$0.04n/m-$0.05n/m-$0.05n/m-$0.05n/m-$0.03n/m-$0.04n/m-$0.04n/m-$0.08n/m-$0.04n/m-$0.08n/m-$0.05n/m-$0.10n/m

What diluted earnings per share means

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.

More Zai Lab Limited financials

Frequently Asked Questions

Zai Lab Limited lost $0.16 per diluted ordinary share in fiscal year 2025.

Zai Lab Limited (ZLAB) reported a loss of $0.26 per diluted ordinary share in fiscal year 2024 and a loss of $0.16 per diluted ordinary share in fiscal year 2025. A growth rate is not meaningful here, because the earlier figure was zero or negative.

Zai Lab Limited (ZLAB) reported a loss of $0.19 per diluted ordinary share over the trailing 12 months, Q4 FY2025 through Q3 FY2026, summed from the four most recent quarterly filings.

Across the 11 fiscal years this page covers, Zai Lab Limited (ZLAB) diluted earnings per share went from -$2.07 in fiscal year 2015 to -$0.16 in fiscal year 2025.

Zai Lab Limited (ZLAB) reported -$0.04 in diluted earnings per share in Q3 2026. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative.

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what Zai Lab Limited (ZLAB) reported on that line in every period on record.

Earnings and dividends per share are per ordinary share, and share counts are in ordinary shares. ZLAB trades in the US as American depositary shares (ADSs), and one ADS represents 10 ordinary shares. The -$0.16 of fiscal year 2025 comes to about -$1.60 per ADS.